Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Hypertension Research
  • View all journals
  • Search
  • Log in
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. hypertension research
  3. original article
  4. article
Beneficial Effect of T-Type Calcium Channel Blockers on Endothelial Function in Patients with Essential Hypertension
Download PDF
Download PDF
  • Original Article
  • Published: 01 November 2005

Beneficial Effect of T-Type Calcium Channel Blockers on Endothelial Function in Patients with Essential Hypertension

  • Tetsuya Oshima1,
  • Ryoji Ozono1,
  • Yoko Yano1,
  • Yukihito Higashi2,
  • Hiroki Teragawa3,
  • Narimasa Miho3,
  • Takafumi Ishida3,
  • Mari Ishida3,
  • Masao Yoshizumi2 &
  • …
  • Masayuki Kambe1 

Hypertension Research volume 28, pages 889–894 (2005)Cite this article

  • 2033 Accesses

  • Metrics details

Abstract

Endothelial function is impaired in essential hypertension. T-type but not L-type voltage-gated Ca2+ channels were detected in the vascular endothelium. The purpose of the present study was to clarify the role of T-type Ca2+ channels in endothelial function. We studied flow-mediated vasodilation (FMD) and sublingual nitroglycerin (NTG)-induced vasodilation in the brachial artery. Forty patients with essential hypertension were randomly assigned to treatment with efonidipine, a T- and L-type Ca2+ channel blocker, or with nifedipine, an L-type Ca2+ channel blocker. Twenty healthy normotensive individuals were included as a control group. In patients with essential hypertension, FMD was attenuated and NTG was similar that of compared to healthy controls. After 12 weeks, the decrease in mean blood pressure in the efonidipine and nifedipine groups were similar. The endothelial function index, a ratio of FMD/NTG, was significantly increased by efonidipine (73±24 to 94±20%) but unchanged by nifedipine. Urinary excretion 8-hydroxy-2′-deoxyguanosine (8-OHdG) and serum malondialdehyde-modified low-density lipoprotein (LDL) were decreased by efonidipine but unchanged by nifedipine. These results suggest that a T-type Ca2+ channel blocker, but not an L-type Ca2+ channel blocker, may improve vascular endothelial dysfunction in patients with essential hypertension via a reduction in oxidative stress.

Similar content being viewed by others

The vascular endothelial growth factor trap aflibercept induces vascular dysfunction and hypertension via attenuation of eNOS/NO signaling in mice

Article 10 December 2020

The relationship between continuation of exercise habit for three years and endothelial function in patients with hypertension

Article Open access 05 December 2024

Downregulated calmodulin expression contributes to endothelial cell impairment in diabetes

Article 19 July 2023

Article PDF

References

  1. Ross A : Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 115–126.

    Article  CAS  PubMed  Google Scholar 

  2. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE : Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22–27.

    Article  CAS  PubMed  Google Scholar 

  3. Moriguchi J, Itoh H, Harada S, et al: Low frequency regular exercise improves flow-mediated dilation of subjects with mild hypertension. Hypertens Res 2005; 28: 315–321.

    Article  PubMed  Google Scholar 

  4. Higashi Y, Oshima T, Ozono R, Matsuura H, Kajiyama G : Aging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans. Hypertension 1997; 30: 252–258.

    Article  CAS  PubMed  Google Scholar 

  5. Egashira K, Suzuki S, Hirooka Y, et al: Impaired endothelium-dependent vasodilation in large epicardial and resistance coronary arteries in patients with essential hypertension. Hypertension 1995; 25: 201–206.

    Article  CAS  PubMed  Google Scholar 

  6. Tarutani Y, Matsumoto T, Takashima H, Yamane T, Horie M : Brachial artery flow-mediated vasodilation is correlated with coronary vasomotor and fibrinolytic response induced by bradykinin. Hypertens Res 2005; 28: 59–66.

    Article  CAS  PubMed  Google Scholar 

  7. Staessen JA, Li Y, Thijs L, Wang JG : Blood pressure reduction and cardiovascular prevention: an update including the 2003–2004 secondary prevention trials. Hypertens Res 2005; 28: 385–407.

    Article  PubMed  Google Scholar 

  8. Ghiadoni L, Magagna A, Versari D, et al: Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003; 41: 1281–1286.

    Article  CAS  PubMed  Google Scholar 

  9. Iwatsubo H, Nagano M, Sakai T, et al: Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension. Hypertension 1997; 29: 286–290.

    Article  CAS  PubMed  Google Scholar 

  10. Hirooka Y, Imaizumi T, Masaki H, et al: Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension 1992; 20: 175–180.

    Article  CAS  PubMed  Google Scholar 

  11. Millgard J, Hagg A, Sarabi M, Lind L : Captopril, but not nifedipine, improves endothelium-dependent vasodilation in hypertensive patients. J Hum Hypertens 1998; 12: 511–516.

    Article  CAS  PubMed  Google Scholar 

  12. Taddei S, Virdis A, Ghiadoni L, et al: Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. Hypertension 2001; 37: 943–948.

    Article  CAS  PubMed  Google Scholar 

  13. Wu S, Haynes J, Taylor JT, et al: Cav 3.1 (α1G) T-type Ca2+ channels mediate vaso-occlusion of sickled erythrocytes in lung microcirculation. Circ Res 2003; 93: 346–353.

    Article  CAS  PubMed  Google Scholar 

  14. Yazawa K, Ono K, Iijima T : Modulation by mibefradil of the histamine-induced Ca2+ entry in human aoritic endothelial cells. Jpn J Pharmacol 2002; 90: 125–130.

    Article  CAS  PubMed  Google Scholar 

  15. Nilius B, Prenen J, Kamouchi M, Viana F, Voets T, Droogmans G : Inhibition by mibefradil, a novel calcium antagonist, of Ca2+- and volume-activated Cl− channels in macrovascular endothelial cells. Br J Pharmacol 1997; 121: 547–555.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Masumiya H, Shijuku T, Tanaka H, Shigenobu K : Infibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect. Eur J Pharmacol 1998; 349: 351–357.

    Article  CAS  PubMed  Google Scholar 

  17. Oshima T, Ozono R, Yano Y, et al: Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 2005; 45: 1219–1222.

    Article  CAS  PubMed  Google Scholar 

  18. Boulanger CM, Nakashima M, Olmos L, Joly G, Vanhoutte PM : Effects of the Ca2+ antagonist RO 40–5967 on endothelium-dependent responses of isolated arteries. J Cardiovasc Pharmacol 1994; 23: 869–876.

    Article  CAS  PubMed  Google Scholar 

  19. Boulanger CM, Desta B, Clozel JP, Vanhoutte PM : Chronic treatment with the Ca2+ channel inhibitor RO 40–5967 potentiates endothelium-dependent relaxations in the aorta of the hypertensive salt sensitive Dahl rat. Blood Press 1994; 3: 193–196.

    Article  CAS  PubMed  Google Scholar 

  20. Nomura S, Kanazawa S, Fukuhara S : Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. J Hum Hypertens 2002; 16: 539–547.

    Article  CAS  PubMed  Google Scholar 

  21. Hagiwara N, Irisawa H, Kameyama M : Contribution of two types of calcium currents to the pacemaker potentials of rabbit sinoatrial node cells. J Physiol 1988; 395: 233–253.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Tseng GN, Boyden PA : Multiple types of Ca2+ currents in single canine Purkinje cells. Circ Res 1989; 65: 1735–1750.

    Article  CAS  PubMed  Google Scholar 

  23. Chen C, Lamping KG, Nuno DW, et al: Abnormal coronary function in mice deficient in α1H T-type Ca2+ channels. Science 2003; 302: 1416–1418.

    Article  CAS  PubMed  Google Scholar 

  24. Vanbavel E, Sorop O, Andreasen D, Pfaffendorf M, Jensen BL : Role of T-type calcium channels in myogenic tone of skeletal muscle resistance arteries. Am J Physiol 2002; 283: H2239–H2243.

    CAS  Google Scholar 

  25. Hornig B, Landmesser U, Kohler C : Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on the biovailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 2001; 103: 799–805.

    Article  CAS  PubMed  Google Scholar 

  26. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K : Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002; 346: 1954–1962.

    Article  CAS  PubMed  Google Scholar 

  27. Maggi E, Marchesi E, Ravette V, Martignoni A, Finardi G, Bellomo G : Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation. J Hypertens 1995; 13: 129–138.

    Article  CAS  PubMed  Google Scholar 

  28. Mak TI, Boehme P, Weglicki WB : Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Circ Res 1992; 70: 1099–1103.

    Article  CAS  PubMed  Google Scholar 

  29. Umemoto S, Tanaka M, Kawahara S, et al: Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats. Hypertens Res 2004; 27: 877–885.

    Article  CAS  PubMed  Google Scholar 

  30. Yasunari K, Maeda K, Nakamura M, Watanabe T, Yoshikawa J : Benidipine, a long-acting calcium channel blocker, inhibits oxidative stress in polymorphonuclear cells in patients with essential hypertension. Hypertens Res 2005; 28: 107–112.

    Article  CAS  PubMed  Google Scholar 

  31. Correti MC, Anderson TJ, Benjamin EJ, et al: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 2002; 39: 257–265.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Laboratory Medicine, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan

    Tetsuya Oshima, Ryoji Ozono, Yoko Yano & Masayuki Kambe

  2. Department of Cardiovascular Physiology and Medicine, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan

    Yukihito Higashi & Masao Yoshizumi

  3. Department of Medicine and Molecular Science, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan

    Hiroki Teragawa, Narimasa Miho, Takafumi Ishida & Mari Ishida

Authors
  1. Tetsuya Oshima
    View author publications

    Search author on:PubMed Google Scholar

  2. Ryoji Ozono
    View author publications

    Search author on:PubMed Google Scholar

  3. Yoko Yano
    View author publications

    Search author on:PubMed Google Scholar

  4. Yukihito Higashi
    View author publications

    Search author on:PubMed Google Scholar

  5. Hiroki Teragawa
    View author publications

    Search author on:PubMed Google Scholar

  6. Narimasa Miho
    View author publications

    Search author on:PubMed Google Scholar

  7. Takafumi Ishida
    View author publications

    Search author on:PubMed Google Scholar

  8. Mari Ishida
    View author publications

    Search author on:PubMed Google Scholar

  9. Masao Yoshizumi
    View author publications

    Search author on:PubMed Google Scholar

  10. Masayuki Kambe
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Tetsuya Oshima.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oshima, T., Ozono, R., Yano, Y. et al. Beneficial Effect of T-Type Calcium Channel Blockers on Endothelial Function in Patients with Essential Hypertension. Hypertens Res 28, 889–894 (2005). https://doi.org/10.1291/hypres.28.889

Download citation

  • Received: 07 July 2005

  • Accepted: 05 September 2005

  • Issue date: 01 November 2005

  • DOI: https://doi.org/10.1291/hypres.28.889

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • calcium
  • endothelium
  • nitroglycerin
  • vasodilation
  • ion channels

This article is cited by

  • Efonidipine Exerts Cerebroprotective Effect by Down-regulation of TGF-β/SMAD-2-Dependent Signaling Pathway in Diabetic Rats

    • Rashmi Rajput
    • Vishal Chavda
    • Ghulam Md Ashraf

    Journal of Molecular Neuroscience (2021)

  • Pathophysiological roles and therapeutic potential of voltage-gated ion channels (VGICs) in pain associated with herpesvirus infection

    • Qiaojuan Zhang
    • Miguel Martin-Caraballo
    • Shaochung V. Hsia

    Cell & Bioscience (2020)

  • Deficiency of T-type voltage-gated calcium channels results in attenuated weight gain and improved endothelium-dependent dilatation of resistance vessels induced by a high-fat diet in mice

    • Kristoffer Rosenstand
    • Kenneth Andersen
    • Per Svenningsen

    Journal of Physiology and Biochemistry (2020)

  • In vitro study of carbon black nanoparticles on human pulmonary artery endothelial cells: effects on calcium signaling and mitochondrial alterations

    • J. Deweirdt
    • J. F. Quignard
    • I. Baudrimont

    Archives of Toxicology (2020)

  • Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise

    • Annabella Braschi

    American Journal of Cardiovascular Drugs (2019)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • Open Access Fees and Funding
  • Guide to Authors
  • About the Editors
  • Message from Editors
  • Call for Paper
  • Contact
  • About the Partner
  • For Advertisers
  • Subscribe
  • Showcase of Graphical Abstracts on Hypertension Research

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Hypertension Research (Hypertens Res)

ISSN 1348-4214 (online)

ISSN 0916-9636 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited